XIDF-AWS801, Angio Workstation (Alphenix Workstation), V9.5

The XIDF-AWS801 Angio Workstation V9.5 is an image processing system integral to interventional fluoroscopic procedures, designed to provide 2D and 3D imaging for selective catheter angiography by managing image input, processing, and display. This updated version enhances its Dynamic Device Stabilizer software with deep learning algorithms to significantly improve the detection rate of stent markers, thereby aiming for greater procedural accuracy and more reliable real-time device visualization.

The XIDF-AWS801, also known as the Angio Workstation or Alphenix Workstation, version V9.5, is an advanced image processing system designed to be used with interventional angiography systems (such as Alphenix, Infinix-i, and INFX series) that employ image-intensified fluoroscopic x-ray technology. Its primary function is to facilitate 2D and 3D imaging for selective catheter angiography procedures across the entire body, including critical areas like the heart, chest, abdomen, brain, and extremities. The workstation processes images inputted from these diagnostic systems, enhancing and displaying them, with the capability to output processed images back to the systems or for storage. When integrated with a Dose Tracking System (DTS), it also supports dose monitoring for angiography procedures in regions like the heart, chest, abdomen, pelvis, and brain. The V9.5 iteration of the Angio Workstation introduces a significant modification centered on its Dynamic Device Stabilizer (DDS) software. This updated DDS software now incorporates deep learning algorithms specifically engineered to enhance the detection rate of stent markers during interventional procedures. Verification and validation through bench testing have demonstrated that the V9.5 algorithm provides improved fixed display performance for the DDS when compared to the previous V9.3 version, suggesting more reliable visualization. Alongside this key DDS enhancement, version V9.5 also bundles other software improvements, including electronic licenses for Transcatheter Aortic Valve Replacement (TAVR) and Cardiovascular Angiography Analysis System (CAAS), CT DICOM support, an improved 3D roadmap feature, and better serviceability through Smart Update, ensuring the system's performance is at least equivalent to, if not better than, its predecessor.

AI Regulatory Concerns

Powered by

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

• Q1. How does the deep learning algorithm in the Dynamic Device Stabilizer (V9.5) specifically improve stent marker detection accuracy and robustness compared to conventional image processing techniques used in V9.3?; What quantitative metrics were used to validate the "improved fixed display performance" of the Dynamic Device Stabilizer in V9.5, and what was the magnitude of this improvement over V9.3?; Can the improved stent marker detection by the Dynamic Device Stabilizer lead to quantifiable reductions in procedure time, radiation dose, or contrast media usage during selective catheter angiography?; How does the integration of CT DICOM support in V9.5 enhance the workflow or diagnostic capabilities of the Angio Workstation during complex interventional procedures?; What are the specific failure modes or limitations of the deep learning-based stent marker detection, particularly in challenging scenarios such as overlapping devices, poor image quality, or with novel stent designs?